Histotype
Ovarian
| Parameter | Information |
|---|---|
| Strain | C57BL/6 Albino |
| Implant Type | Cells |
| Implant Location | IP |
| Time to Staging | 14 days |
| Time to 750mm3 | 24 days |
| Td | 8.3 days |
The above parameters are from one study. For further information on this cell line and other parameters, including different strains, vendors, implant type and location and/or standards of care, please contact us.
Tumor Line
Mouse
Ref #
9153
Spotlight on ID8-Luc
Learn more about this cell line in our scientific spotlights:
In our November 2017 model spotlight, we described the development of a novel syngeneic mouse model of orthotopic ovarian cancer, ID8-Luc. Ovarian cancer remains a significant unmet medical need with a relative 5-year survival rate of 17% in patients diagnosed with highly advanced stage IV ovarian cancer. While often initially responsive to platinum- and taxane-based chemotherapy, relapse is common in ovarian cancer.